/ /

  • linkedin
  • Increase Font
  • Sharebar

    The CEO that nobody loves


    With what he thought was a shrewd business move, Shkreli touched a nerve. According to the Kaiser Family Foundation, 77% of Americans surveyed consider high drug prices to be a primary health concern, and this unloved chap is now officially the public face for this issue and a lightning rod for the angst and anger of that same public.

    An ironic twist in this story is that, according to many, the hero saving the day is Imprimis Pharmaceuticals, owner of three compounding pharmacies, who announced it will sell the drug for $1 per dose. Compounding pharmacies, regulated as they are by the states and not the FDA, do not require the same license to make this medicine.

    The irony is that compounding pharmacies were not long ago about as popular as Shkreli is today, related to an outbreak of fungal meningitis complicating the use of specially compounded steroids. 


    • http://www.bbc.com/news/world-us-canada-34331761

    • http://www.deathandtaxesmag.com/264328/martin-shkreli-katie-ex-girlfriend-facebook-eat-out/

    Peter McDonnell, MD
    He is director of The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, and chief medical editor of ...

    New Call-to-action

    1 Comment

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • Remy JayRemy Jay


    View Results